Skip to main content

End-of-Life Issues: Management of Cardiac Implantable Electronic Devices

Abstract

It has become increasingly acceptable for clinicians to disable cardiac devices placed in a patient if the patient so requests. When deactivation was first proposed, there was significant resistance. However, with the rise of patient autonomy, the recognition that quality of life is a patient judgment and the increased burdens of multiple chronic illnesses patients face as they live longer, device deactivation is a reasonable approach in end-of-life care. The three intracardiac devices (pacemaker, automatic implantable cardioverter defibrillator and ventricular assist device) have different benefits, burdens and deactivation trajectories. This chapter will review the commonalities and differences and suggest some talking points when there is a request for deactivation.

Keywords

  • End-of-Life
  • Ethics
  • Deactivation
  • Pacemakers
  • Automatic Implantable Cardioverter Defibrillators
  • Ventricular Assist Devices

This is a preview of subscription content, access via your institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-3-319-15949-2_14
  • Chapter length: 14 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   119.00
Price excludes VAT (USA)
  • ISBN: 978-3-319-15949-2
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book
USD   159.00
Price excludes VAT (USA)
Hardcover Book
USD   159.00
Price excludes VAT (USA)

References

  1. Lampert R, Hayes DL, Annas GJ, Farley MA, Goldstein NE, Hamilton RM, et al. HRS expert consensus statement on the management of cardiovascular implantable electronic devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm. 2010;7(7):1008–26.

    CrossRef  PubMed  Google Scholar 

  2. Allen LA, Stevenson LW, Grady KL, Goldstein NF, Matlock DD, Arnold RM, et al. Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation. 2012;125(5):1928–52.

    CrossRef  PubMed  PubMed Central  Google Scholar 

  3. Mueller PS, Swetz KM, Freeman MR, Carter KA, Crowley ME, Severson CJ, Park SJ, Sulmasy DP. Ethical analysis of withdrawing ventricular assist device support. Mayo Clin Proc. 2010;85(9):791–7.

    CrossRef  PubMed  PubMed Central  Google Scholar 

  4. Huddle TS, Bailey FA. Pacemaker deactivation: withdrawal of support or active ending of life. Theor Med Bioeth. 2012;33(6):421–33.

    CrossRef  PubMed  Google Scholar 

  5. Kinzbrunner BM. Jewish medical ethics and end-of-life. J Palliat Med. 2004;7(4):558–73.

    CrossRef  PubMed  Google Scholar 

  6. Miller FG, Truog RD, Brock DW. Moral fictions and medical ethics. Bioethics. 2010;24(9):453–60.

    CrossRef  PubMed  Google Scholar 

  7. Butler K. Knocking on heaven’s door: the path to a better way of death. New York: Scribner; 2014. p. 1–3.

    Google Scholar 

  8. Rhymes JA, McCullough LB, Luchi RJ, Teasdale TA, Wilson N. Withdrawing very low-burden interventions in chronically ill patients. JAMA. 2000;283(8):1061–3.

    CAS  CrossRef  PubMed  Google Scholar 

  9. Pelligrino ED. Decision to withdraw life-sustaining treatment. JAMA. 2000;283(8):1065–7.

    CrossRef  Google Scholar 

  10. Whitlock SN, Goldberg IP, Singh JP. Is pacemaker deactivation at the end of life unique?: a case study and ethical analysis. J Palliat Med. 2011;14(10):1184–8.

    CrossRef  PubMed  Google Scholar 

  11. Mueller PS, Hook C, Hayes DL. Ethical analysis of withdrawal of pacemaker or implantable cardio-defibrillator support at the end of life. Mayo Clin Proc. 2003;78(8):959–63.

    CrossRef  PubMed  Google Scholar 

  12. Jauhar S. Jolts of anxiety. New York Times. 5 May 2002.

    Google Scholar 

  13. Kohn CS, Petrucci RJ, Baessler C, Soto DM, Mosowitz C. The effects of psychological intervention on patient’s long-term adjustments to the ICD: a prospective study. PACE. 2000;23(4):450–6.

    CAS  CrossRef  PubMed  Google Scholar 

  14. Paola FA, Walker RM. Deactivating the implantable cardioverter-defibrillator: a biofixture analysis. South Med J. 2000;93(1):20–3.

    CAS  CrossRef  PubMed  Google Scholar 

  15. Sulmasy DP. Within you/without you: biotechnology, ontology and ethics. J Gen Intern Med. 2008;23(S1):69–72.

    CrossRef  PubMed  Google Scholar 

  16. Matlock DD, Stevenson LW. Life-saving devices reach the end of life with heart failure. Prog Cardiovasc Dis. 2012;55(3):274–81.

    CrossRef  PubMed  PubMed Central  Google Scholar 

  17. Hauptman PJ, Havranek EP. Integrating palliative care into heart failure care. Arch Int Med. 2005;165(4):374–8.

    CrossRef  Google Scholar 

  18. Yuan N, Arnaoutakis GJ, Georg TJ, Allen JG, Ju DG, Schaffer JM, et al. The spectrum of complications following left ventricular assist device placement. J Card Surg. 2012;27(5):630–8.

    CrossRef  PubMed  Google Scholar 

  19. Brush S, Budge D, Alharethi R, McCormick AJ, MacPherson JE, Reid BB, et al. End-of-life decision making and implementation in recipients of a destination left ventricular assist device. J Heart Lung Transplant. 2010;29(12):1337–41.

    CrossRef  PubMed  Google Scholar 

  20. Bruce C. A review of ethical considerations for ventricular assist device placement in older adults. Aging Dis. 2013;4(2):100–12.

    PubMed  PubMed Central  Google Scholar 

  21. Swetz KM, Freeman MR, AbouEzzeddine OF, Carter KA, Boilson BA, Ottenberg AL, et al. Palliative medicine consultation for preparedness planning in patients receiving left ventricular assist devices as destination therapy. Mayo Clin Proc. 2011;86(6):493–500.

    CrossRef  PubMed  PubMed Central  Google Scholar 

  22. Hupcey JE, Penrod J, Fenstermacher K. A model of palliative care for heart failure. Am J Hosp Palliat Med. 2009;26(5):399–404.

    CrossRef  Google Scholar 

  23. Quaglietti S, Pham M, Froelicher V. A palliative care approach to the advanced heart failure patient. Curr Card Rev. 2005;1(1):45–52.

    CrossRef  Google Scholar 

  24. Butler K, Puri S. Deathbed shock: causes and cures. JAMA Int Med. 2014;174(1):88–9.

    CrossRef  Google Scholar 

  25. Pasalic D, Tajouri TH, Ottenberg AL, Mueller PS. The prevalence and contents of advance directives in patients with pacemakers. PACE. 2014;37(4):473–80.

    CrossRef  PubMed  Google Scholar 

  26. Tajouri TH, Ottenberg AL, Hayes DL, Mueller PS. The use of advance directives among patients with implantable cardiac defibrillators. PACE. 2012;35(5):567–73.

    CrossRef  PubMed  Google Scholar 

  27. Fromme EK, Stewart TL, Jeppesen M, Tolle SW. Adverse experiences with implantable defibrillators in Oregon hospices. Am J Hosp Palliat Med. 2011;28(5):304–9.

    CrossRef  Google Scholar 

  28. Mueller PS, Ottenberg AL, Hayes DL, Koenig BA. “I felt like the angel of death”: role conflicts and moral distress among allied professionals employed by the US cardiovascular implantable electronic device industry. J Interv Card Electrophysiol. 2011;32(3):253–61.

    CrossRef  PubMed  Google Scholar 

  29. Bevins MB. The ethics of pacemaker deactivation in terminally ill patients. J Pain Symp Manage. 2011;41(6):1106–10.

    CrossRef  Google Scholar 

  30. Buchhalter LC, Al O, Webster TL, Swetz KM, Hayes DL, Mueller PS. Features and outcomes of patients who underwent cardiac device deactivation. JAMA Intern Med. 2014;174(1):80–5.

    CrossRef  PubMed  PubMed Central  Google Scholar 

  31. Jacob S, Panaich SS, Maheshwari R, Haddad JW, Padanilam BJ, John SK. Clinical applications of magnets on cardiac rhythm devices. Europace. 2011;13(9):1222–30.

    CrossRef  PubMed  Google Scholar 

  32. Kramer DB, Ottenberg AL, Gerhardson S, Mueller KA, Kaufman SR, Koenig BA, Mueller PS. “Just because we can doesn’t mean we should”: views of nurses on deactivation of pacemakers and implantable cardio-defibrillators. J Inter Card Electrophysiol. 2011;32(3):243–52.

    CrossRef  Google Scholar 

  33. Stolberg SG. On medicine’s frontier: the last journey of James Quinn. The New York Times. 8 Oct 2002.

    Google Scholar 

  34. Jolly D. Recipient of artificial heart goes home. The New York Times. 9 Jan 2015.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cynthiane J. Morgenweck MD, MA .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and Permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Morgenweck, C.J. (2015). End-of-Life Issues: Management of Cardiac Implantable Electronic Devices. In: Jericho, B. (eds) Ethical Issues in Anesthesiology and Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-15949-2_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-15949-2_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-15948-5

  • Online ISBN: 978-3-319-15949-2

  • eBook Packages: MedicineMedicine (R0)